Wave Life Sciences (WVE) Cash from Operations (2014 - 2026)
Wave Life Sciences (WVE) posted Cash from Operations of 59553000.0 for Q1 2026, down 76.32% on a QoQ basis from 33776000.0 in Q4 2025, and up 5.53% year-over-year from 56432342.23 in Q1 2025.
Wave Life Sciences (WVE) Cash from Operations (2014 - 2026) Analysis & Trends
Wave Life Sciences' Cash from Operations history runs 13 years deep, the most recent figure standing at 59553000.0 for Q1 2026.
- Quarterly Cash from Operations rose 5.53% year-over-year to 59553000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 184007000.0 (down 1.87% YoY) and the FY2025 annual result came in at 187493000.0, down 24.15% from the prior year.
- Cash from Operations was 59553000.0 for Q1 2026 at Wave Life Sciences, down from 33776000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 85522000.0 in Q1 2023 and bottomed at 63039000.0 in Q1 2025.
- A 5-year average of 32075529.41 and a median of 34457000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 375.47% — and 2023, when it soared 314.49%.
- Wave Life Sciences' Cash from Operations stood at 33440000.0 in 2022, then gained by 0.6% to 33239000.0 in 2023, then tumbled by 31.32% to 43648000.0 in 2024, then grew by 22.62% to 33776000.0 in 2025, then tumbled by 76.32% to 59553000.0 in 2026.
- Business Quant data shows WVE's Cash from Operations at 59553000.0 in Q1 2026, 33776000.0 in Q4 2025, and 44666000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -59.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.55 Mn |
| Mar 31, 2026 | -59.55 Mn |
| Dec 31, 2025 | -33.78 Mn |
| Dec 31, 2025 | -33.78 Mn |
| Sep 30, 2025 | -44.67 Mn |
| Sep 30, 2025 | -44.67 Mn |
| Jun 30, 2025 | -46.01 Mn |
| Jun 30, 2025 | -46.01 Mn |
| Mar 31, 2025 | -63.04 Mn |
| Mar 31, 2025 | -63.04 Mn |
| Dec 31, 2024 | -43.65 Mn |
| Dec 31, 2024 | -43.65 Mn |
| Sep 30, 2024 | -46.48 Mn |
| Sep 30, 2024 | -46.48 Mn |
| Jun 30, 2024 | -27.47 Mn |
| Jun 30, 2024 | -27.47 Mn |
| Mar 31, 2024 | -33.43 Mn |
| Mar 31, 2024 | -33.43 Mn |
| Dec 31, 2023 | -33.24 Mn |
| Dec 31, 2023 | -33.24 Mn |